FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4249432170> ?p ?o ?g. }

• W4249432170 endingPage "376" @default.
• W4249432170 startingPage "359" @default.
• W4249432170 abstract "Human Gene TherapyVol. 2, No. 4 News and CommentsAutologous Bone Marrow Transplantation for CML in Which Retroviral Markers Are Used to Discriminate Between Relapse Which Arises from Systemic Disease Remaining after Preparative Therapy Versus Relapse due to Residual Leukemia Cells in Autologous Marrow: A Pilot Trial. The University of Texas M.D. Anderson Cancer CenterPublished Online:12 Jun 2008https://doi.org/10.1089/hum.1991.2.4-359AboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail FiguresReferencesRelatedDetailsCited byGene transfer: methods and applicationsClinical gene-marking of mesenchymal cellsCytotherapy, Vol. 5, No. 3Is retroviral gene marking too dangerous to use?Cytotherapy, Vol. 5, No. 3Apport des biothérapies anticancéreuses dans le traitement des leucémies de l’enfantArchives de Pédiatrie, Vol. 9, No. 3Gene therapy for paediatric leukaemia23 February 2005 | Expert Opinion on Biological Therapy, Vol. 1, No. 4Gene-Marking studies of hematopoietic cellsInternational Journal of Hematology, Vol. 73, No. 1Viral Vectors for Gene TransferDrugs, Vol. 60, No. 2Gene Marking in Bone Marrow and Peripheral Blood Stem Cell TransplantationGene Marking to Establish the Biology of Minimal Residual Disease and RelapseGenetic engineering: Moral aspects and control of practiceJournal of Assisted Reproduction and Genetics, Vol. 14, No. 6Gene therapy of solid tumors and hematopoietic neoplasmsGene Marking20 March 2008 | Human Gene Therapy, Vol. 7, No. 16Bone Marrow and Clinical Gene Therapy27 March 2009 | Journal of Hematotherapy, Vol. 4, No. 6Gene-marking and haemopoietic stem-cell transplantationBlood Reviews, Vol. 9, No. 4Recent advances in the application of gene therapy to human diseaseThe American Journal of Medicine, Vol. 99, No. 5Human somatic gene therapy: progress and problemsJournal of Internal Medicine, Vol. 237, No. 3The Role of the Blood Bank in Human Gene Therapy TrialsThe contribution of marker gene studies to hemopoietic stem cell therapies23 December 2008 | STEM CELLS, Vol. 13, No. 5Human cancer and gene therapyAnnals of Hematology, Vol. 69, No. 6Retrovirus-mediated gene transfer in cancer therapyPharmacology & Therapeutics, Vol. 63, No. 3Current trends and future directions in the genetic therapy of human neoplastic diseaseCancer, Vol. 72, No. 7Current trends and future directions in the genetic therapy of human neoplastic diseaseCancer, Vol. 72, No. 7Gene Transfer into Human Hematopoietic Progenitor Cells: A Review of Current Clinical Protocols8 May 2009 | Journal of Hematotherapy, Vol. 2, No. 1Gene Therapy of Cancer11 June 2009 | Cancer Investigation, Vol. 11, No. 6Human Gene TherapyScience, Vol. 256, No. 5058Trying to Overcome Residual Disease After Bone Marrow Transplantation for Hematologic Malignancies1 July 2009 | Leukemia & Lymphoma, Vol. 8, No. 6Cancer Gene Therapy Volume 2Issue 4Dec 1991 InformationCopyright 1992, Mary Ann Liebert, Inc.To cite this article:Autologous Bone Marrow Transplantation for CML in Which Retroviral Markers Are Used to Discriminate Between Relapse Which Arises from Systemic Disease Remaining after Preparative Therapy Versus Relapse due to Residual Leukemia Cells in Autologous Marrow: A Pilot Trial. The University of Texas M.D. Anderson Cancer Center.Human Gene Therapy.Dec 1991.359-376.http://doi.org/10.1089/hum.1991.2.4-359Published in Volume: 2 Issue 4: June 12, 2008PDF download" @default.
• W4249432170 created "2022-05-12" @default.
• W4249432170 date "1991-12-01" @default.
• W4249432170 modified "2023-10-17" @default.
• W4249432170 title "Autologous Bone Marrow Transplantation for CML in Which Retroviral Markers Are Used to Discriminate Between Relapse Which Arises from Systemic Disease Remaining after Preparative Therapy Versus Relapse due to Residual Leukemia Cells in Autologous Marrow: A Pilot Trial. The University of Texas M.D. Anderson Cancer Center" @default.
• W4249432170 cites W2050042349 @default.
• W4249432170 cites W2061808904 @default.
• W4249432170 cites W2122455557 @default.
• W4249432170 doi "https://doi.org/10.1089/hum.1991.2.4-359" @default.
• W4249432170 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1665350" @default.
• W4249432170 hasPublicationYear "1991" @default.
• W4249432170 type Work @default.
• W4249432170 citedByCount "25" @default.
• W4249432170 crossrefType "journal-article" @default.
• W4249432170 hasConcept C104317684 @default.
• W4249432170 hasConcept C109159458 @default.
• W4249432170 hasConcept C111599444 @default.
• W4249432170 hasConcept C121608353 @default.
• W4249432170 hasConcept C126322002 @default.
• W4249432170 hasConcept C143998085 @default.
• W4249432170 hasConcept C194409129 @default.
• W4249432170 hasConcept C203014093 @default.
• W4249432170 hasConcept C2778461978 @default.
• W4249432170 hasConcept C2779823535 @default.
• W4249432170 hasConcept C2780007613 @default.
• W4249432170 hasConcept C28328180 @default.
• W4249432170 hasConcept C2911091166 @default.
• W4249432170 hasConcept C502942594 @default.
• W4249432170 hasConcept C54355233 @default.
• W4249432170 hasConcept C71924100 @default.
• W4249432170 hasConcept C86803240 @default.
• W4249432170 hasConceptScore W4249432170C104317684 @default.
• W4249432170 hasConceptScore W4249432170C109159458 @default.
• W4249432170 hasConceptScore W4249432170C111599444 @default.
• W4249432170 hasConceptScore W4249432170C121608353 @default.
• W4249432170 hasConceptScore W4249432170C126322002 @default.
• W4249432170 hasConceptScore W4249432170C143998085 @default.
• W4249432170 hasConceptScore W4249432170C194409129 @default.
• W4249432170 hasConceptScore W4249432170C203014093 @default.
• W4249432170 hasConceptScore W4249432170C2778461978 @default.
• W4249432170 hasConceptScore W4249432170C2779823535 @default.
• W4249432170 hasConceptScore W4249432170C2780007613 @default.
• W4249432170 hasConceptScore W4249432170C28328180 @default.
• W4249432170 hasConceptScore W4249432170C2911091166 @default.
• W4249432170 hasConceptScore W4249432170C502942594 @default.
• W4249432170 hasConceptScore W4249432170C54355233 @default.
• W4249432170 hasConceptScore W4249432170C71924100 @default.
• W4249432170 hasConceptScore W4249432170C86803240 @default.
• W4249432170 hasIssue "4" @default.
• W4249432170 hasLocation W42494321701 @default.
• W4249432170 hasLocation W42494321702 @default.
• W4249432170 hasOpenAccess W4249432170 @default.
• W4249432170 hasPrimaryLocation W42494321701 @default.
• W4249432170 hasRelatedWork W1978598034 @default.
• W4249432170 hasRelatedWork W2000925826 @default.
• W4249432170 hasRelatedWork W2062228169 @default.
• W4249432170 hasRelatedWork W2119511363 @default.
• W4249432170 hasRelatedWork W2253242983 @default.
• W4249432170 hasRelatedWork W2381639528 @default.
• W4249432170 hasRelatedWork W2412102303 @default.
• W4249432170 hasRelatedWork W2979078421 @default.
• W4249432170 hasRelatedWork W3103783692 @default.
• W4249432170 hasRelatedWork W4210379329 @default.
• W4249432170 hasVolume "2" @default.
• W4249432170 isParatext "false" @default.
• W4249432170 isRetracted "false" @default.
• W4249432170 workType "article" @default.